CD103+ cDC1s, although representing a minor tumor-infiltrating population in murine melanoma, were shown to be the predominant vehicles for transporting tumor antigens (TAs) to the tumor-draining lymph nodes (tdLNs) and were key in promoting anti-PD-L1 mediated anti-tumor immunity [48]. The gene discussed is ITGAE; the disease is melanoma.